Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
Users Online: 78
Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Login 

    Article Cited by others


Hypothesis: The potential application of doxorubicin against cutaneous leishmaniasis

Keighobadi Masoud, Fakhar Mahdi, Emami Saeed

Year : 2015| Volume: 5| Issue : 1 | Page no: 69-70

   This article has been cited by
1 Alkyl and Aryl Derivatives Based on p-Coumaric Acid Modification and Inhibitory Action against Leishmania braziliensis and Plasmodium falciparum
Susiany P. Lopes,Lina M. Yepes,Yunierkis Pérez-Castillo,Sara M. Robledo,Damião P. de Sousa
Molecules. 2020; 25(14): 3178
[Pubmed]  [Google Scholar] [DOI]
2 Promising antileishmanial effectiveness of doxorubicin and Doxil against Leishmania major : An in vitro assay
Azar Shokri,Javad Akhtari,Masoud Keighobadi,Mahdi Fakhar,Saeed Hosseini Teshnizi,Saeed Emami,Sajede Sadjjadian
Asian Pacific Journal of Tropical Medicine. 2017;
[Pubmed]  [Google Scholar] [DOI]
3 Case Report: No Response to Liposomal Daunorubicin in a Patient with Drug-Resistant HIV-Associated Visceral Leishmaniasis
Nicholas J. Gow,Robert N. Davidson,Rob Ticehurst,Andrew Burns,Mark G. Thomas,Carlos Franco-Paredes
PLOS Neglected Tropical Diseases. 2015; 9(8): e0003983
[Pubmed]  [Google Scholar] [DOI]


Read this article